+674.0%
MRNA vs BIIB
-33.1%
+707.1%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | BIIB | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +0.8% | +4.6% | +5.1% |
| 7D | -1.1% | -1.7% | +0.6% | -0.5% |
| 30D | +126.1% | +4.0% | +122.2% | +126.1% |
| 3M | +190.0% | +8.6% | +181.4% | +185.7% |
| 6M | +157.2% | +14.0% | +143.2% | +149.7% |
| YTD | +388.2% | +23.4% | +364.8% | +362.5% |
| 1Y | +467.0% | +45.9% | +421.1% | +413.9% |
| 3Y | +36.1% | -16.1% | +52.2% | +39.1% |
| 5Y | -68.0% | -27.6% | -40.4% | -67.0% |
| All | +674.0% | -33.1% | +707.1% | +663.2% |
Cumulative growth
Daily Returns
Daily percentage return beside BIIB.
Daily Out/Under-Performance
Portfolio return minus BIIB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BIIB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded BIIB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling